Tom Meek

Healthcare journalist covering pharma industry for @apmhealtheurope. Used to run comedy nights in London: @laughoutlondon. Now living in Ely

[Tom Meek @tmeek87]

Following another big conference for @apmhealtheurope next week: Reuters Events Pharma (@RE_Pharma) in Barcelona. There will certainly be a lot to talk about...

And stories to follow on the website

https://t.co/K8Y413g0Aw

[Tom Meek @tmeek87]

Two weeks until touching down in Barcelona for another Reuters Events Pharma (@RE_Pharma). It's going to be a packed few days. And lots of content to follow on @apmhealtheurope

https://t.co/K8Y413fsKY

[Tom Meek @tmeek87]

Just a few weeks until Reuters Events Pharma (@RE_Pharma) in Barcelona. Always an interesting one. We'll have comprehensive coverage on @apmhealtheurope https://t.co/K8Y413fsKY

[Tom Meek @tmeek87]

Looking forward to #EPAconf 2023 in Amsterdam later this month. Very interesting time for drug pricing
and access! https://t.co/zoG6G7aFur

[Peter O'Donnell @podeuropa]

So that’s it - the @EU_Health proposals on new #Pharmaceutical rules have now slipped from March 14 to March 29 on the @EU_Commission agenda of upcoming meetings…

[Tom Meek @tmeek87]

I'll be attending @CAR_TCell Europe conference in London next week. Looking like a busy couple of days https://t.co/Ttztbgs3eF

[APM Health Europe @apmhealtheurope]

Industry response to @NICEComms's plans for updating its evaluation processes has been broadly positive.
Read more on the plans and the reaction at https://t.co/Nwiwpzy9Co

#NICE #pharma #HTA #HEOR

[APM Health Europe @apmhealtheurope]

"We think the biggest drivers of change [in drug pricing] over the next decade will be employers", says @icer_review's Sarah Emond.

Read the full interview at https://t.co/XD55yMKDgR

Lots of interesting thoughts on Aduhelm and wider state of drug value assessment in U.S.

[journalist jobs @journ_jobs]

APM Health Europe (@apmhealtheurope, ein englischsprachiger Nachrichtendienst, der über die Gesundheitspolitik und die pharmazeutische Industrie berichtet, sucht einen Healthcare Journalist (w/m/d) am Standort Berlin. Alle Infos: https://t.co/MakaosPqwk

[Helene Mauduit @helenemauduit]

I am #hiring - @apmhealtheurope is looking for a #Berlin-based journalist, fluent in German and English, to write on #health policy & #pharma - young professional welcome! Please contact me #berlinjobs #Gesundheitspolitik #journalismjobs #newswriting https://t.co/0So452KH6a

[APM Health Europe @apmhealtheurope]

A senior Labour MP has called the UK government's plans to undermine the Northern Ireland protocol, including the potential removal of medicines, as "despicable".

Read more: https://t.co/YSehxmV9Qb

#pharma #NIprotocol #Brexit

[Tom Meek @tmeek87]

UK government suggests "the simplest way forward may be to remove all medicines from the scope" of the N Ireland protocol due to supply/access issues.

Read more: https://t.co/H4FCPIROoY

#brexit #NIProtocol #pharma

[Tom Meek @tmeek87]

EU 'ready to discuss' how U.S. proposal to waive IP protections for Covid-19 vaccines could address pandemic, says EC president Ursula von der Leyen (@vonderleyen ).

Read more: https://t.co/6DAI3gi3Mv

#pharma #vaccines #WaiveThePatents #covid19

[APM Health Europe @apmhealtheurope]

"We are hearing a lot of suggestions that they want to tax #pharma companies... but the proceeds will just fall in the black hole of the federal budget" - Pfizer (@pfizer_news) CEO Albert Bourla discusses potential drug pricing reforms in U.S.

Read more: https://t.co/xNFcAfgIoJ

[APM Health Europe @apmhealtheurope]

EU regulators recommend J&J's Covid vaccine carry blood clot warning similar to AstraZeneca's Vaxzevria.

Read more: https://t.co/R7uVQd5utw

#covid19 #covid #vaccines

[APM Health Europe @apmhealtheurope]

EU regulators now investigating link between J&J's Covid vaccine and blood clot.

Read more: https://t.co/PY0BqFHde0

#covid19 #vaccines #janssen

[APM Health Europe @apmhealtheurope]

Experts have advised they have not been able to identify risk factors for link between AZN's Covid vaccine and serious blood clots, says EMA head Emer Cooke.

"No evidence that would support restricting the use of this vaccine in any population"
#covid19 #coronavirus #AstraZeneca

[APM Health Europe @apmhealtheurope]

How is the UK @MHRAgovuk's new reliance route for drug approvals? We spoke to Seagen's EVP, commercial international to find out after the company received UK approval for its breast cancer drug.

Read more: https://t.co/6hz8V38SBQ

#pharma #brexit #MHRA

[APM Health Europe @apmhealtheurope]

EMA's safety committee is recommending label of AZN's Covid vaccine be updated to include risk on possible link to rare blood clots with low blood platelets. But benefits still outweigh risks.

Read more: https://t.co/clmV16PRR3

#covid19 #astrazeneca #vaccines #PRAC

[Tom Meek @tmeek87]

EMA's safety committee PRAC has come to "clear and scientific conclusion that this is a safe and effective vaccine" after review of risk of blood clots in AstraZeneca vaccine, says executive director Emer Cooke in ongoing press conference.